Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.

Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B.

J Natl Cancer Inst. 1995 Sep 20;87(18):1372-82.

PMID:
7658498
2.

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

Dunn BK, Ford LG.

Breast J. 2001 May-Jun;7(3):144-57. Review.

PMID:
11469927
3.

Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

Vogel VG.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Review.

PMID:
11916233
4.

Chemoprevention for high-risk women: tamoxifen and beyond.

Fabian CJ, Kimler BF.

Breast J. 2001 Sep-Oct;7(5):311-20. Review.

PMID:
11906441
5.

Prevention of breast cancer in high-risk women.

Kardinal CG, Veith R.

J La State Med Soc. 1999 Apr;151(4):198-201. Review.

PMID:
10234895
6.

Breast cancer prevention with selective estrogen receptor modulators: a perspective.

Pritchard KI.

Ann N Y Acad Sci. 2001 Dec;949:89-98. Review.

PMID:
11795385
7.

Prevention of hormone-related cancers: breast cancer.

Dunn BK, Wickerham DL, Ford LG.

J Clin Oncol. 2005 Jan 10;23(2):357-67. Review.

PMID:
15637398
8.

Breast cancer prevention trials.

Rhodes DJ, Hartmann LC, Perez EA.

Curr Oncol Rep. 2000 Nov;2(6):558-65. Review.

PMID:
11122893
9.

Chemoprevention of breast cancer in the older patient.

Minton SE.

Hematol Oncol Clin North Am. 2000 Feb;14(1):113-30. Review.

PMID:
10680075
10.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
11.

Heath-related quality of life in Spanish breast cancer patients: a systematic review.

Delgado-Sanz MC, García-Mendizábal MJ, Pollán M, Forjaz MJ, López-Abente G, Aragonés N, Pérez-Gómez B.

Health Qual Life Outcomes. 2011 Jan 14;9:3. doi: 10.1186/1477-7525-9-3. Review.

12.

Chemoprevention of breast cancer.

Powles TJ, Davey J, McKinna A.

Acta Oncol. 1989;28(6):865-7. Review.

PMID:
2692649
13.

Patient-reported outcomes in breast oncology: a review of validated outcome instruments.

Kanatas A, Velikova G, Roe B, Horgan K, Ghazali N, Shaw RJ, Rogers SN.

Tumori. 2012 Nov;98(6):678-88. doi: 10.1700/1217.13489. Review.

14.

Cancer-related infertility in survivorship.

Carter J, Chi DS, Brown CL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Levine DA, Baser RE, Raviv L, Barakat RR.

Int J Gynecol Cancer. 2010 Jan;20(1):2-8. doi: 10.1111/IGC.0b013e3181bf7d3f. Review.

PMID:
20130497
15.

Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative view.

Costantino JP, Vogel VG.

Clin Breast Cancer. 2001 Apr;2(1):41-6. Review.

PMID:
11899381
16.

Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction.

Carmichael AR, Daley AJ, Rea DW, Bowden SJ.

Eur J Surg Oncol. 2010 Dec;36(12):1139-48. doi: 10.1016/j.ejso.2010.09.011. Epub 2010 Oct 13. Review.

PMID:
20947287
17.

The Breast Cancer Prevention Trial: evaluating tamoxifen's efficacy in preventing breast cancer.

McKeon VA.

J Obstet Gynecol Neonatal Nurs. 1997 Jan-Feb;26(1):79-90. Review.

PMID:
9017550
18.

[Prevention of breast cancer in elderly women: a review].

de Carvalho CM, de Brito CM, Nery IS, Figueiredo Mdo L.

Rev Bras Enferm. 2009 Jul-Aug;62(4):579-82. Review. Portuguese.

19.

[Methods of Assesing Quality of Life in Women with Breast Cancer -  Overview and Basic Characteristics].

Holoubková E, Skřivanová K, Nedvěd J, Jarkovský J.

Klin Onkol. 2015;28(5):332-7. Review. Czech.

PMID:
26480860
20.

Design and current status of the NSABP breast cancer prevention trial.

Redmond CK, Costantino JP.

Recent Results Cancer Res. 1996;140:309-17. Review.

PMID:
8787073

Supplemental Content

Support Center